Literature DB >> 21665989

APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.

Jean Schneikert1, Katharina Brauburger, Jürgen Behrens.   

Abstract

The germline transmission of a mutation in the adenomatous polyposis coli (APC) gene leads to cancer of the gastro-intestinal tract upon somatic inactivation of the remaining allele in familial adenomatous polyposis (FAP) patients. APC mutations result in truncated products that have primarily lost the ability to properly regulate the level of the transcription factor β-catenin. However, colorectal cancer cells from FAP patients always retain a truncated APC product and the reasons for this strong selective pressure are not understood. We describe here the surprising property for the transcriptional repressor C-terminal binding protein (CtBP) to promote the oligomerization of truncated APC through binding to the 15 amino acid repeats of truncated APC. CtBP can bind to either first, third or fourth 15 amino acid repeats, but not to the second. CtBP-mediated oligomerization requires both dimerization domains of truncated APC as well as CtBP dimerization. The analysis of the position of the mutations along the APC sequence in adenomas from FAP patients reveals that the presence of the first 15 amino acid repeat is almost always selected in the resulting truncated APC product. This suggests that the sensitivity of truncated APC to oligomerization by CtBP constitutes an essential facet of tumour development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665989     DOI: 10.1093/hmg/ddr273

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

Review 1.  The β-catenin destruction complex.

Authors:  Jennifer L Stamos; William I Weis
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

2.  The Adenomatous polyposis coli tumour suppressor is essential for Axin complex assembly and function and opposes Axin's interaction with Dishevelled.

Authors:  Carolina Mendoza-Topaz; Juliusz Mieszczanek; Mariann Bienz
Journal:  Open Biol       Date:  2011-11       Impact factor: 6.411

Review 3.  Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy.

Authors:  Xiuyan Yang; Jie Zhong; Qiufen Zhang; Li Feng; Zhen Zheng; Jian Zhang; Shaoyong Lu
Journal:  Front Mol Biosci       Date:  2021-04-22

Review 4.  Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?

Authors:  David P Minde; Zeinab Anvarian; Stefan Gd Rüdiger; Madelon M Maurice
Journal:  Mol Cancer       Date:  2011-08-22       Impact factor: 27.401

5.  Regulation of Wnt signaling by the tumor suppressor adenomatous polyposis coli does not require the ability to enter the nucleus or a particular cytoplasmic localization.

Authors:  David M Roberts; Mira I Pronobis; John S Poulton; Eric G Kane; Mark Peifer
Journal:  Mol Biol Cell       Date:  2012-04-18       Impact factor: 4.138

6.  Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.

Authors:  Jean Schneikert; Shree Harsha Vijaya Chandra; Jan Gustav Ruppert; Suparna Ray; Eva Maria Wenzel; Jürgen Behrens
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

7.  C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Int J Cell Biol       Date:  2013-05-20

8.  The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.

Authors:  Maria Vittoria Enzo; Marco Rastrelli; Carlo Riccardo Rossi; Uros Hladnik; Daniela Segat
Journal:  Mol Cell Ther       Date:  2015-01-30

9.  different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.

Authors:  Jean Schneikert; Jan Gustav Ruppert; Jürgen Behrens; Eva Maria Wenzel
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.

Authors:  Oksana Voloshanenko; Gerrit Erdmann; Taronish D Dubash; Iris Augustin; Marie Metzig; Giusi Moffa; Christian Hundsrucker; Grainne Kerr; Thomas Sandmann; Benedikt Anchang; Kubilay Demir; Christina Boehm; Svenja Leible; Claudia R Ball; Hanno Glimm; Rainer Spang; Michael Boutros
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.